Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical data show AdCOVID neutralizes SARS-CoV-2 B.1.351 variant

May 28, 2021

New biomarkers found to monitor disease progression in eosinophilic esophagitis

May 28, 2021

DSMB recommends continuation of uniQure's phase I/II trial of AMT-130 in Huntington's disease

May 28, 2021

OSE's COVID-19 vaccine CoVepiT enters first-in-human study

May 28, 2021

Topical bevacizumab-800CW is safe for detecting esophageal lesions during NIR-FME

May 28, 2021

Activation of MT2 reduces cardiac I/R injury in prediabetic rats

May 28, 2021

China NMPA approves CTA for phase IIb trial of AM-006 in Parkinson's disease

May 28, 2021

Gene signature governs anti-plaque microglia in AD

May 28, 2021

Oncorus announces development plans for its novel synthetic vRNA immunotherapy candidates

May 28, 2021

FDA accepts IND application for LY-3819469

May 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...